Evidence map›Paper›PMID 41228396›Full record

ArticleNutrients2025

The Phosphate/Urea Nitrogen Ratio in Urine-A Method to Assess the Relative Intake of Inorganic Phosphate.

Carlos Novillo, Raquel M García-Saez, Laura Sánchez-Molina, Cristian Rodelo-Haad, Andrés Carmona, Gonzalo Pinaglia-Tobaruela, Cristina Membrives-González, Daniel Jurado, Rafael Santamaría, Juan R Muñoz-Castañeda and 4 more

Abstract read
In one paragraph

Article in Nutrients, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Phosphate and Inflammation in Health and Kidney Disease.International journal of molecular sciences · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Carlos NovilloUnidad de Gestión Clínica Nefrología, Reina Sofia University Hospital, 14004 Cordoba, Spain.
Raquel M García-SaezInstituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Unidad de Gestión Clínica Nefrología, Reina Sofia University Hospital, Department of Medicine, University of Cordoba, 14004 Cordoba, Spain.ORCID 0009-0001-8502-3564
Laura Sánchez-MolinaDepartment of Medicine, University of Cordoba, 14004 Cordoba, Spain.
Cristian Rodelo-HaadInstituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Unidad de Gestión Clínica Nefrología, Reina Sofia University Hospital, Department of Medicine, University of Cordoba, 14004 Cordoba, Spain.ORCID 0000-0002-8139-3840
Andrés CarmonaInstituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Unidad de Gestión Clínica Nefrología, Reina Sofia University Hospital, Department of Medicine, University of Cordoba, 14004 Cordoba, Spain.ORCID 0000-0002-1830-2096
Gonzalo Pinaglia-TobaruelaInstituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Unidad de Gestión Clínica Nefrología, Reina Sofia University Hospital, Department of Medicine, University of Cordoba, 14004 Cordoba, Spain.
Cristina Membrives-GonzálezInstituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Unidad de Gestión Clínica Nefrología, Reina Sofia University Hospital, Department of Medicine, University of Cordoba, 14004 Cordoba, Spain.
Daniel JuradoInstituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Unidad de Gestión Clínica Nefrología, Reina Sofia University Hospital, Department of Medicine, University of Cordoba, 14004 Cordoba, Spain.
Rafael SantamaríaInstituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Unidad de Gestión Clínica Nefrología, Reina Sofia University Hospital, Department of Medicine, University of Cordoba, 14004 Cordoba, Spain.ORCID 0000-0002-2627-1445
Juan R Muñoz-CastañedaInstituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Unidad de Gestión Clínica Nefrología, Reina Sofia University Hospital, Department of Medicine, University of Cordoba, 14004 Cordoba, Spain.ORCID 0000-0002-9341-0724
Alejandro Martín-MaloInstituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Unidad de Gestión Clínica Nefrología, Reina Sofia University Hospital, Department of Medicine, University of Cordoba, 14004 Cordoba, Spain.ORCID 0000-0002-8010-7187
Mariano RodríguezInstituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Unidad de Gestión Clínica Nefrología, Reina Sofia University Hospital, Department of Medicine, University of Cordoba, 14004 Cordoba, Spain.ORCID 0000-0002-9380-6614
Sagrario SorianoInstituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Unidad de Gestión Clínica Nefrología, Reina Sofia University Hospital, Department of Medicine, University of Cordoba, 14004 Cordoba, Spain.
Victoria Pendón-RuizdeMierInstituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Unidad de Gestión Clínica Nefrología, Reina Sofia University Hospital, Department of Medicine, University of Cordoba, 14004 Cordoba, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

objectivesIt would be desirable to reduce the intake of inorganic phosphate (P), which is easily absorbed and is associated with cardiovascular disease. The phosphate-to-urea nitrogen ratio (P/UUN) in urine should reflect the proportion of inorganic P ingested relative to protein intake. In this manuscript, we will refer to this parameter as P/UUN, which is conceptually equivalent to the phosphate-to-urea ratio (P/U). These studies aim to evaluate whether an increased intake of inorganic P translates into an increase in the P/UUN.

methodsA total of 18 healthy volunteers (Study-1) and 18 chronic kidney disease patients (Study-2) were included. At baseline, all participants completed a 3-day dietary survey, and on the third day collected a 24 h urine sample. In Study-2, blood samples were also obtained. Participants were then stratified into three groups (6 per group) for a 3-day dietary intervention: control group: maintained their usual diet; soda group: consumed soda zero, a source of added inorganic P; and processed cheese group: consumed fresh processed cheese, which includes both organic and inorganic P additives. At last visit, all participants again completed a 3-day dietary survey and collected a 24 h urine sample (and blood samples in Study-2). Dietary P intake was estimated using two tools: the diet calibrator and the Spanish Food Composition Database (BEDCA).

resultsAfter the intervention, neither BEDCA nor the diet calibrator was able to provide an accurate measurement of inorganic P ingested. However, only in the soda group, P/UUN increased in both studies (

conclusionsThese findings suggest that urinary P/UUN ratio may be a useful biomarker to monitor changes in inorganic P intake and could help to individualize dietary recommendations to reduce inorganic P exposure without restricting protein intake.

Indexed as

NitrogenPhosphatesRenal Insufficiency, ChronicUreaAdultAgedDietDiet SurveysFemaleHumansMaleMiddle AgedNitrogenPhosphatesUreachronic kidney diseasedietinorganic phosphatenormal renal functionurinary phosphate/urea

Identifiers

PMID41228396
PMCPMC12608474

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.